MINI FUTURE LONG - TANDEM DIABETES CARE Stock

Certificat

DE000MG23084

Real-time Bid/Ask 07:30:01 2024-06-17 EDT
1.89 EUR / 1.96 EUR +1.85% Intraday chart for MINI FUTURE LONG - TANDEM DIABETES CARE
Current month-24.10%
1 month+5.00%
Date Price Change
24-06-17 1.89 0.00%
24-06-14 1.89 -2.07%
24-06-13 1.93 -9.39%
24-06-12 2.13 -1.39%
24-06-11 2.16 -2.26%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 06:13 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer Morgan Stanley
WKN MG2308
ISINDE000MG23084
Date issued 2024-04-10
Strike 24.85 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.82
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.62
Lowest since issue 0.54
Spread 0.07
Spread %3.57%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
45.33 USD
Average target price
49.93 USD
Spread / Average Target
+10.16%
Consensus